efavirenz has been researched along with Liver Failure, Acute in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burt, AD; Daly, AK; Elsharkawy, AM; Hudson, M; Masson, S; McCarron, B; Schwab, U | 1 |
Ball, C; Gilmour-White, S; Mieli-Vergani, G; Rela, M; Turkova, A | 1 |
2 other study(ies) available for efavirenz and Liver Failure, Acute
Article | Year |
---|---|
Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser.
Topics: Adult; Alkynes; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Female; Genetic Predisposition to Disease; HIV Infections; Humans; Liver Failure, Acute; Liver Transplantation | 2013 |
A paediatric case of acute liver failure associated with efavirenz-based highly active antiretroviral therapy and effective use of raltegravir in combination antiretroviral treatment after liver transplantation.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Cyclopropanes; HIV Infections; Humans; Liver Failure, Acute; Liver Transplantation; Pyrrolidinones; Raltegravir Potassium | 2009 |